rs2288021

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_178452.6(DNAAF1):​c.1975C>G​(p.Leu659Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.203 in 1,613,716 control chromosomes in the GnomAD database, including 34,915 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L659P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.16 ( 2577 hom., cov: 33)
Exomes 𝑓: 0.21 ( 32338 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.430

Publications

18 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 16-84176209-C-G is Benign according to our data. Variant chr16-84176209-C-G is described in ClinVar as Benign. ClinVar VariationId is 163088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_178452.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF1
NM_178452.6
MANE Select
c.1975C>Gp.Leu659Val
missense
Exon 11 of 12NP_848547.4
DNAAF1
NM_001318756.1
c.1267C>Gp.Leu423Val
missense
Exon 7 of 8NP_001305685.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF1
ENST00000378553.10
TSL:1 MANE Select
c.1975C>Gp.Leu659Val
missense
Exon 11 of 12ENSP00000367815.5
DNAAF1
ENST00000569735.1
TSL:2
c.277C>Gp.Leu93Val
missense
Exon 1 of 3ENSP00000454960.1
DNAAF1
ENST00000564928.1
TSL:2
c.67C>Gp.Leu23Val
missense
Exon 1 of 2ENSP00000457899.1

Frequencies

GnomAD3 genomes
AF:
0.164
AC:
24898
AN:
152118
Hom.:
2576
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0412
Gnomad AMI
AF:
0.173
Gnomad AMR
AF:
0.203
Gnomad ASJ
AF:
0.224
Gnomad EAS
AF:
0.112
Gnomad SAS
AF:
0.209
Gnomad FIN
AF:
0.202
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.220
Gnomad OTH
AF:
0.186
GnomAD2 exomes
AF:
0.199
AC:
50022
AN:
250950
AF XY:
0.202
show subpopulations
Gnomad AFR exome
AF:
0.0375
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.226
Gnomad EAS exome
AF:
0.120
Gnomad FIN exome
AF:
0.213
Gnomad NFE exome
AF:
0.220
Gnomad OTH exome
AF:
0.207
GnomAD4 exome
AF:
0.207
AC:
302398
AN:
1461480
Hom.:
32338
Cov.:
70
AF XY:
0.208
AC XY:
150975
AN XY:
727048
show subpopulations
African (AFR)
AF:
0.0357
AC:
1194
AN:
33480
American (AMR)
AF:
0.217
AC:
9719
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
5743
AN:
26136
East Asian (EAS)
AF:
0.0975
AC:
3870
AN:
39700
South Asian (SAS)
AF:
0.214
AC:
18422
AN:
86256
European-Finnish (FIN)
AF:
0.211
AC:
11212
AN:
53078
Middle Eastern (MID)
AF:
0.279
AC:
1609
AN:
5768
European-Non Finnish (NFE)
AF:
0.214
AC:
238319
AN:
1111974
Other (OTH)
AF:
0.204
AC:
12310
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15861
31722
47584
63445
79306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8122
16244
24366
32488
40610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.164
AC:
24891
AN:
152236
Hom.:
2577
Cov.:
33
AF XY:
0.162
AC XY:
12030
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0411
AC:
1707
AN:
41562
American (AMR)
AF:
0.203
AC:
3096
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
777
AN:
3470
East Asian (EAS)
AF:
0.111
AC:
576
AN:
5170
South Asian (SAS)
AF:
0.208
AC:
1006
AN:
4830
European-Finnish (FIN)
AF:
0.202
AC:
2147
AN:
10606
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.220
AC:
14958
AN:
67992
Other (OTH)
AF:
0.186
AC:
394
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1035
2069
3104
4138
5173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.208
Hom.:
1129
Bravo
AF:
0.159
TwinsUK
AF:
0.207
AC:
768
ALSPAC
AF:
0.201
AC:
775
ESP6500AA
AF:
0.0436
AC:
192
ESP6500EA
AF:
0.218
AC:
1878
ExAC
AF:
0.197
AC:
23939
Asia WGS
AF:
0.137
AC:
476
AN:
3478
EpiCase
AF:
0.221
EpiControl
AF:
0.221

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu659Val in exon 11 of DNAAF1: This variant is not expected to have clinical si gnificance because it has been identified in 21.8% (1878/8600) of European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs2288021).

Primary ciliary dyskinesia Benign:2
Nov 26, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 13 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
4.1
DANN
Benign
0.89
DEOGEN2
Benign
0.0058
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.31
T
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.34
N
PhyloP100
-0.43
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.17
N
REVEL
Benign
0.032
Sift
Uncertain
0.022
D
Sift4G
Benign
0.093
T
Polyphen
0.013
B
Vest4
0.020
MPC
0.020
ClinPred
0.0023
T
GERP RS
0.29
PromoterAI
0.039
Neutral
Varity_R
0.049
gMVP
0.059
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.32
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.32
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288021; hg19: chr16-84209815; COSMIC: COSV58987654; COSMIC: COSV58987654; API